v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net loss $ (74,069) $ (50,920)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,448 3,117
Foreign exchange gain on long-term debt (33) (8)
Bad debt expense 170 182
Gain on extinguishment of debt (2,096)
Change in fair value of warrants and derivatives (3,016) (7,045)
Non-cash debt amendment fee 463
Share-based compensation 19,399 2,150
Total adjustments 20,431 (3,700)
Changes in operating assets and liabilities:    
Decrease in accounts receivable 15,615 18,001
Decrease (increase) in inventory 1,596 (1,957)
Decrease (increase) in prepaid expenses and other current assets 1,571 (452)
Decrease in other non-current assets 555 6
Decrease in accounts payable (3,895) (15,799)
Increase (decrease) in deferred revenue 651 (2,476)
Increase in accrued expenses and other current liabilities 7,498 5,599
(Decrease) increase in other long-term liabilities (7,738) 468
Increase in accrued interest on long-term debt 8,160 5,917
Net cash used in operating activities (29,625) (45,313)
Cash flows from investing activities:    
Purchase of property, plant and equipment (2,156) (4,287)
Net cash used in investing activities (2,156) (4,287)
Cash flows from financing activities:    
Proceeds from the Business Combination, issuance of convertible debt and PIPE financing, net of issuance costs paid 115,501
Repayments of senior term loan (3,960)
Proceeds from the exercise of stock options 78
Payment for taxes withheld on stock awards (73)
Proceeds from the sale of Series H stock, net 505
Proceeds from the issuance of Series H warrants 142
Net cash (used in) provided by financing activities (4,033) 116,226
Net (decrease) increase in cash, cash equivalents and restricted cash (35,814) 66,626
Cash, cash equivalents and restricted cash, beginning of year 63,122 18,618
Cash, cash equivalents and restricted cash, end of period 27,308 85,244
Supplemental disclosures of cash flow information    
Cash paid for interest 4,417 8,045
Cash paid for income taxes 318 552
Supplemental disclosure of non-cash financing activities:    
Reclassification of redeemable convertible preferred stock warrants to common stock 10,284
Non-cash net liabilities assumed from Business Combination 38
Cash and cash equivalents 27,265 85,058
Restricted cash 43 186
Total cash, cash equivalents and restricted cash shown in the unaudited condensed consolidated statement of cash flows $ 27,308 $ 85,244

Source